Arbutus Biopharma Corporation
ABUSNASDAQHealthcare● Active
$4.29
+$0.05(+1.06%)
Market Cap$846449087
P/E Ratio—
52W High$5.1
52W Low$3.04
Arbutus Biopharma Corporation (ABUS) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ABUS · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $91.47M | $122.62M | $126.00M | $146.91M | $155.32M |
| Net Receivables | $1.75M | $2.41M | $1.78M | $1.35M | $0.90M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $94.46M | $127.32M | $132.03M | $151.14M | $160.66M |
| PP&E Net | $0.03M | $4.36M | $6.09M | $6.81M | $8.07M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $94.62M | $131.71M | $144.40M | $195.42M | $204.49M |
| Liabilities | |||||
| Short-Term Debt | $0.55M | $0.00M | $0.00M | $0.37M | $0.00M |
| Accounts Payable | $1.17M | $2.32M | $3.22M | $3.52M | $3.17M |
| Total Current Liabilities | $6.01M | $15.62M | $22.49M | $32.86M | $11.22M |
| Long-Term Debt | $3.44M | $0.00M | $6.95M | $10.37M | $16.30M |
| Total Liabilities | $18.04M | $34.34M | $38.38M | $58.57M | $35.05M |
| Stockholders Equity | |||||
| Retained Earnings | ($1380.07M) | ($1346.57M) | ($1276.65M) | ($1203.80M) | ($1134.35M) |
| Total Stockholders Equity | $76.58M | $97.37M | $106.02M | $136.85M | $169.44M |
| Total Liab & Equity(computed) | $94.62M | $131.71M | $144.40M | $195.42M | $204.49M |
| Debt Summary | |||||
| Total Debt | $4.19M | $1.29M | $8.72M | $12.55M | $18.91M |
| Net Debt | ($13.82M) | ($35.04M) | ($17.56M) | ($18.22M) | ($90.37M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Arbutus Biopharma Corporation data
About Arbutus Biopharma Corporation (ABUS) Balance Sheet
Arbutus Biopharma Corporation (ABUS) balance sheet shows total assets of $0.09B with cash of $0.09B. Total liabilities are $0.02B, total debt $0.00B, and stockholders equity $0.08B.
Frequently asked questions
ABUS · 4 questionsArbutus Biopharma Corporation has total debt of $0.00B with net debt of ($0.01B).
ABUS total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10